DarioHealth Corp.

NASDAQ: DRIO · Real-Time Price · USD
0.43
-0.07 (-14.51%)
At close: Aug 12, 2025, 3:59 PM

DarioHealth Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
27.04M 20.35M 27.66M 20.51M
Cost of Revenue
13.77M 14.37M 18M 16.55M
Gross Profit
13.27M 5.98M 9.65M 3.96M
Operating Income
-57.74M -56.19M -56.81M -76.49M
Interest Income
1.12M 1.87M 506K 44K
Pretax Income
-44.6M -59.36M -62.19M -76.73M
Net Income
-42.75M -59.43M -62.19M -76.76M
Selling & General & Admin
46.83M 41.8M 46.82M 63.24M
Research & Development
24.18M 20.25M 19.65M 17.22M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
71.01M 62.17M 66.47M 80.46M
Interest Expense
96K 645K 2.68M 84K
Selling & Marketing Expenses
26.35M 23.79M 30.32M 39.71M
Cost & Expenses
84.78M 76.41M 84.47M 97.01M
Income Tax Expense
-1.85M 64K 4K 32K
Shares Outstanding (Basic)
67.18M 28.37M 23.64M 16.59M
Shares Outstanding (Diluted)
67.18M 28.37M 23.64M 16.59M
EPS (Basic)
-0.61 -1.93 -2.63 -4.63
EPS (Diluted)
-0.61 -1.93 -2.63 -4.63
EBITDA
-50.32M -54.38M -56.81M -73.12M
EBIT
-57.74M -59.36M -60.31M -76.73M
Depreciation & Amortization
7.43M 4.99M 3.8M 3.53M